Arbutus Biopharma Corp Quarterly Debt-to-equity in % from Q3 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Arbutus Biopharma Corp quarterly Debt-to-equity history and growth rate from Q3 2014 to Q3 2024.
  • Arbutus Biopharma Corp Debt-to-equity for the quarter ending September 30, 2024 was 32.3 %, a 7.88% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 32.3 -2.76 -7.88% Sep 30, 2024
Q2 2024 32.6 -4.14 -11.3% Jun 30, 2024
Q1 2024 32.8 -6.4 -16.3% Mar 31, 2024
Q4 2023 33.2 -8.51 -20.4% Dec 31, 2023
Q3 2023 35 -0.79 -2.21% Sep 30, 2023
Q2 2023 36.8 +3.76 +11.4% Jun 30, 2023
Q1 2023 39.2 +8.06 +25.9% Mar 31, 2023
Q4 2022 41.7 +15 +56.4% Dec 31, 2022
Q3 2022 35.8 +5.13 +16.7% Sep 30, 2022
Q2 2022 33 +0.31 +0.95% Jun 30, 2022
Q1 2022 31.1 -4.02 -11.4% Mar 31, 2022
Q4 2021 26.7 -11.9 -30.9% Dec 31, 2021
Q3 2021 30.7 -10.8 -26% Sep 30, 2021
Q2 2021 32.7 -10.6 -24.5% Jun 30, 2021
Q1 2021 35.1 +3.68 +11.7% Mar 31, 2021
Q4 2020 38.6 +14.2 +58% Dec 31, 2020
Q3 2020 41.5 +22.8 +122% Sep 30, 2020
Q2 2020 43.3 +28.4 +190% Jun 30, 2020
Q1 2020 31.4 +16.5 +110% Mar 31, 2020
Q4 2019 24.4 +9.24 +60.9% Dec 31, 2019
Q3 2019 18.7 +0.06 +0.32% Sep 30, 2019
Q2 2019 15 -9.86 -39.7% Jun 30, 2019
Q1 2019 15 -17.3 -53.6% Mar 31, 2019
Q4 2018 15.2 -24.8 -62% Dec 31, 2018
Q3 2018 18.6 -22.7 -55% Sep 30, 2018
Q2 2018 24.8 -8.62 -25.8% Jun 30, 2018
Q1 2018 32.2 +4 +14.2% Mar 31, 2018
Q4 2017 39.9 +12.5 +45.7% Dec 31, 2017
Q3 2017 41.3 +14 +51.4% Sep 30, 2017
Q2 2017 33.5 +4.57 +15.8% Jun 30, 2017
Q1 2017 28.2 -2.5 -8.14% Mar 31, 2017
Q4 2016 27.4 -3.76 -12.1% Dec 31, 2016
Q3 2016 27.3 -4.39 -13.9% Sep 30, 2016
Q2 2016 28.9 -3.22 -10% Jun 30, 2016
Q1 2016 30.7 -1.04 -3.28% Mar 31, 2016
Q4 2015 31.2 +0.82 +2.7% Dec 31, 2015
Q3 2015 31.7 +3.74 +13.4% Sep 30, 2015
Q2 2015 32.1 Jun 30, 2015
Q1 2015 31.7 Mar 31, 2015
Q4 2014 30.4 Dec 31, 2014
Q3 2014 27.9 Sep 30, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.